Andrew N. Wilner, MD, FACP, FAAN, a Neurohospitalist at Lawrence and Memorial Hospital, discusses the initial evaluation and the decision making process of initiating treatment.

Disclosure:
Owns stock, stock options, or bonds from: GlaxoSmithKline

For more information on Dr. Wilner, Please visit:
www.DrWilner.org